Patent · US Active

Potency test for vaccine formulations

US9599607B2 · kind B2 · utility

4Cited by

4References

29Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Michelle Allen · De Soto, US
Mark Garrett · Overland Park, US
Urs Peter Bruderer · Kleve, DE

Key dates

Filing date	Jul 1, 2014
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Jul 1, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/04
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to certain methods for the determination of an antigen content of a first antigen in a mixture comprising two or more antigens. The invention also relates to a potency test for an antigen in a combination vaccine. The method allows the determination of the antigen content in a mixture additionally comprising antibodies that are capable of binding with the antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.